INTRODUCTION
Reports suggests the increase of Torque Teno Virus (TTV) replication in human immunodeficiency virus (HIV)-infected patients who are progressing toward AIDS. A high TTV viral load was associated with a low CD4 cell count, indicating a potential role of the immune system in controlling TTV replication (Thom & Petrik, 2007) . Although it remains unclear the role of the immune system in the natural of TTV infection, TTV may act as an opportunistic pathogen (Pifferi et al., 2008; Maggi & Bendinelli, 2009 ). Toxoplasmosis already known as an opportunistic infections in HIV/AIDS patients. Prior to antiretroviral therapy, toxoplasmosis could induce cerebral lesion in AIDS patients (Nissapatorn, 2009) . Moreover, cerebral toxoplasmosis reported in Indonesia (Ganiem et al., 2013; Yunihastuti et al., 2005) indicating the need to diagnose Toxoplasmosis in HIV-infected patients. The presence of triple infection of TTV/Toxoplasma/HIV as well as TTV in Indonesian HIV patients have not been published yet.
MATERIALS AND METHODS
In November 2011, 51 blood samples were collected from HIV patients in Moewardi General Hospital Surakarta. The ethical approval was obtained from the institutional ethical committee review boards of the Faculty of Medicine of Sebelas Maret University and Dr. Moewardi General Hospital, Surakarta, Indonesia. Blood samples were fractionated, aliquoted and kept frozen until further analysis. All procedures were conducted according to the principles of the Declaration of Helsinki. The blood plasma was separated from whole blood with EDTA and subsequently was subjected to the DRG T. gondii IgM Elisa Kit (DRG International, Inc., Springfield, NJ) and DRG T. gondii IgG Elisa Kit (DRG International, Inc.) following to the manufacturer's instructions. All samples were tested in duplo. Viral nucleic acid was extracted using the PureLink Viral RNA/DNA Kit (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. TTV-DNA was detected by nested PCR as described previously (Irshad et al., 2008) . Molecular detection was performed by PCR using the Amplitaq Gold® 360 DNA Polymerase Kit (Invitrogen). Internal amplification controls were included to exclude any false negative results. The corresponding positive controls and one negative control (sterile water) were included in every assay. To prevent PCR contamination, the reagent preparation, sample processing and nested PCR assays were performed in rooms separate from those where the amplified products were analyzed. Aerosol-resistant pipette tips were used throughout the assays. The PCR products were subjected to electrophoresis in 2% agarose gels, which were stained with ethidium bromide and visualized under ultraviolet illumination. The specificity was confirmed by sequencing the amplicons. All samples were at least conducted two times.
RESULTS AND DISCUSSION
All HIV patients (31 women and 20 men) of Voluntary Counseling and Testing in Dr. Moewardi General Hospital Surakarta Indonesia was participated in the study. The average of age of the patients was 33.7 years (range 21-72 years). The mean of T Helper CD4+ absolute counts was 447 cells/ul. All respondents received antiretroviral therapies. The IgM anti Toxoplasma and IgG anti Toxoplasma were positively detected on 23.5% (12/51) and 11.8% (6/51) HIV patients, respectively. By nested PCR, TTV DNA was detected in 25.5% (13/51) patients. Three HIV patients (5.9%, 3/51) were co-infected with TTV and Toxoplasma. All HIV patients co-infected with TTV were positive for IgM anti Toxoplasma. The TTV and Toxoplasma infection in HIV patients may influence the HIV immunopathogenesis. TTV is believed weaken the host's defense mechanisms against other noxae and/or alter the way the organism reacts to them, for example by keeping baseline levels of inflammation elevated, so that the superimposed noxae deal with an already compromised, although subclinical, state of affairs (Maggi & Bendinelli, 2009) . Therefore, the presence of TTV in HIV patients may increase the rapid spreading of Toxoplasma. Toxoplasma itself has ability to decrease the production of Interleukin-12 and Interferon Gamma, and immunomodulate the host immune response (Laliberté & Carruthers, 2008) . However, the mechanism on how TTV and or Toxoplasma influence the host immune response, and wether any influence in pathogenesis, especially in patients infected with HIV remains unclear. In fact, our group research is working on this issues.
